Related Experiment Video
Updated: Nov 6, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Molecular Characterization of, and Antimicrobial Resistance in, Clostridioides difficile from Thailand, 2017-2018
Korakrit Imwattana1,2, Papanin Putsathit3, Daniel R Knight1,4
1School of Biomedical Sciences, The University of Western Australia, Nedlands, Australia.
Abstract:
Antimicrobial resistance (AMR) plays an important role in the pathogenesis and spread of Clostridioides difficile infection (CDI). Many antimicrobials, such as fluoroquinolones, have been associated with outbreaks of CDI globally. This study characterized AMR among clinical C. difficile strains in Thailand, where antimicrobial use remains inadequately regulated. Stool samples were screened for tcdB and positives were cultured. C. difficile isolates were characterized by toxin profiling and PCR ribotyping. Antimicrobial susceptibility testing was performed by agar incorporation, and whole-genome sequencing and AMR genotyping were performed on a subset of strains. There were 321 C. difficile strains isolated from 326 stool samples. The most common toxigenic ribotype (RT) was RT 017 (18%), followed by RTs 014 (12%) and 020 (7%). Resistance to clindamycin, erythromycin, moxifloxacin, and rifaximin was common, especially among RT 017 strains. AMR genotyping revealed a strong correlation between resistance genotype and phenotype for moxifloxacin and rifaximin. The presence of erm-class genes was associated with high-level clindamycin and erythromycin resistance. Point substitutions in the penicillin-binding proteins were not sufficient to confer meropenem resistance, but a Y721S substitution in PBP3 was associated with a 4.37-fold increase in meropenem minimal inhibitory concentration. No resistance to metronidazole, vancomycin, or fidaxomicin was observed.
Insights
Antimicrobial resistance is a key factor in Clostridioides difficile infection (CDI) spread. This study found common resistance to clindamycin, erythromycin, moxifloxacin, and rifaximin in Thai C. difficile strains, particularly RT 017.
Area of Science:
- Microbiology
- Infectious Diseases
- Genomics
Background:
- Antimicrobial resistance (AMR) significantly contributes to the pathogenesis and global spread of Clostridioides difficile infection (CDI).
- Inadequately regulated antimicrobial use in regions like Thailand creates a concerning environment for the emergence and dissemination of resistant pathogens.
- Fluoroquinolones have been previously linked to outbreaks of CDI, highlighting the need for understanding resistance patterns.
Purpose of the Study:
- To characterize antimicrobial resistance (AMR) profiles of clinical Clostridioides difficile strains isolated in Thailand.
- To investigate the genotypic basis of observed antimicrobial resistance through whole-genome sequencing and AMR genotyping.
- To correlate specific genetic markers with phenotypic resistance in C. difficile isolates.
Main Methods:
- Isolation and culture of C. difficile from stool samples, followed by toxin profiling and PCR ribotyping.
- Antimicrobial susceptibility testing using the agar incorporation method.
- Whole-genome sequencing and AMR genotyping on a subset of characterized C. difficile strains.
Main Results:
- 321 C. difficile strains were analyzed, with RT 017 being the most prevalent (18%), followed by RT 014 (12%) and RT 020 (7%).
- High rates of resistance were observed for clindamycin, erythromycin, moxifloxacin, and rifaximin, particularly in RT 017 strains.
- AMR genotyping confirmed strong genotype-phenotype correlations for moxifloxacin and rifaximin resistance. erm-class genes were linked to high-level clindamycin/erythromycin resistance. A specific PBP3 substitution (Y721S) was associated with increased meropenem MIC, though not sufficient for resistance.
Conclusions:
- Clostridioides difficile strains in Thailand exhibit significant resistance to commonly used antimicrobials like clindamycin, erythromycin, moxifloxacin, and rifaximin.
- Genetic determinants, including erm-class genes and specific PBP3 mutations, play a role in the observed resistance phenotypes.
- No resistance was detected against metronidazole, vancomycin, or fidaxomicin, suggesting these remain effective treatment options.
More Related Videos
06:51Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Related Concept Videos
Development of Antibiotic Resistance
Modern Molecular Taxonomy
Applications of Molecular Taxonomy
Antimicrobial Effectiveness